Form 4: Control Empresarial de Capitales S.A. de C.V. Increases Stake in ProKidney Corp.
SEC Form 4 Filing
Control Empresarial de Capitales S.A. de C.V. reports acquiring additional Class A Ordinary Shares of ProKidney Corp., increasing their beneficial ownership.
Summary
- Control Empresarial de Capitales S.A. de C.V. filed a Form 4 disclosing changes in their beneficial ownership of ProKidney Corp. shares.
- On April 10, 2025, they acquired 1,032,218 Class A Ordinary Shares at a weighted average price of $0.6081.
- On April 11, 2025, they acquired an additional 1,900 Class A Ordinary Shares at a weighted average price of $0.6081.
- Following these transactions, Control Empresarial beneficially owns 72,594,225 Class A Ordinary Shares.
- This includes 63,118,645 Class B Ordinary Shares, which can be exchanged for Class A Ordinary Shares on a one-for-one basis, and the same number of Common Units in ProKidney LP.
- The Slim Family may be deemed to beneficially own indirectly the Class A Ordinary Shares beneficially owned by Control Empresarial.
- The Slim Family may also be deemed to beneficially own approximately 24.8% of the 292,697,649 total shares issued and outstanding, comprising 129,536,121 Class A Ordinary Shares and 163,161,528 Class B Ordinary Shares, as disclosed in the Issuers Form 10-K filed with the SEC on March 17, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating increased investment by a major shareholder, which could be interpreted as a positive signal, but it doesn't provide enough information to strongly influence sentiment.
Positives
- Increased investment by a major shareholder could be seen as a positive signal.
Industry Context
Form 4 filings are standard disclosures for significant shareholders, providing transparency into their trading activities. This filing indicates continued investment by a major shareholder in ProKidney Corp.
Stakeholder Impact
- Shareholders may view the increased stake by Control Empresarial as a positive sign of confidence in ProKidney Corp.
Key Dates
| Date | Description |
|---|---|
| January 18, 2022 | Date of the Business Combination Agreement between the issuer and ProKidney LP. |
| February 3, 2022 | Date of Schedule 13D/A filed by the Slim Family and Control Empresarial with the SEC. |
| June 10, 2022 | Date of the issuer's Definitive Proxy Statement filed with the SEC. |
| March 17, 2025 | Date of the Issuers Form 10-K filed with the SEC. |
| April 10, 2025 | Date of purchase of 1,032,218 Class A Ordinary Shares. |
| April 11, 2025 | Date of purchase of 1,900 Class A Ordinary Shares. |
| April 14, 2025 | Date of signature of the Form 4. |
Keywords
ProKidney Corp, Control Empresarial, Class A Ordinary Shares, Beneficial Ownership, Form 4, Slim Family
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.